Overview

Smart Inhalers Market Introduction

Global Smart Inhalers Market is estimated to value over USD 1.5 billion by 2027 end and register a CAGR of over 58% during the forecast period 2020 to 2027. 

 The smart inhalers market is growth can be attributed to technological advancements in developing better smart inhaler systems and devices and an increased incidence of people suffering from chronic obstructive pulmonary diseases and asthma. Moreover, untapped  market potential in developing economies with a dearth of healthcare amenities and an ever-increasing population is projected to provide profitable opportunities for themarket trends. 

Nonetheless, higher smart inhaler development costs for COPD and asthma is projected to impede the market growth, due to its unaffordability in the developing economies when compared to the regular inhalers.

Based on the type of indication, the asthma segment accounts for the largest market share, due to the rise in the incidences of people suffering from respiratory diseases such as asthma, bronchitis and other diseases. COPD is projected to be the market segment with the fastest growth rate over the forecast period that would primarily affect the  market growth, the high CAGR rate can be credited to increased adoption of smart inhalers and a rise in the incidence of COPD in the population globally for better treatment of the respiratory diseases. Furthermore, the factors attributing to the adoption of smart inhalers over regular inhalers provide better adherence to the monitoring and medication of the utilization of dose per intake.

 Key market players include Adherium Ltd., AstraZeneca PLC, Boehringer Ingelheim Group, Cohero Health Inc., GlaxoSmithKline plc, Novartis International AG, OPKO Health Inc. ResMed Inc. (Propeller Health), Teva Pharmaceutical Industries Ltd., Vectura Group plc.

 

Smart Inhalers Market Segmentation:

By Product

• Inhalers
• Nebulizers

By Indication

• Asthma
• COPD

 By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa   

FutureWise Key Takeaways:

● Growth Prospects

● SWOT Analysis

● Key Trends

● Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global smart inhalers market by product, by indication, by distribution channel and by region 

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• Evaluate and forecast micro-markets and the overall market 

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East & Africa

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Table of Contents

CHAPTER 1:    INTRODUCTION

1.1.    Report description

1.2.    Research methodology

1.2.1.    Secondary research

1.2.2.    Primary research

1.2.3.    Analyst tools & models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings

2.1.1.    Top investment pockets

 

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope

3.2.    Key forces shaping smart Inhalers market

3.2.1.    Moderate bargaining power of suppliers

3.2.2.    High bargaining power of buyers

3.2.3.    High threat of new entrants

3.2.4.    Moderate threat of substitutes

3.2.5.    High intensity of rivalry

3.3.    Value Chain Analysis

3.5.    Industry pain point analysis

3.6.    Patent Analysis

3.7.    Market share analysis

3.8.    Market Dynamics

3.8.1.    Drivers

3.8.1.1.    Increase in Air Pollution

3.8.1.2.    Increase In Population Susceptible To Indoor Air Pollutants

3.8.1.3.    Increasing Prevalence Of COPD and Asthma ly

3.8.2.    Restraints

3.8.2.1.    Misusing Data And Data Privacy

3.8.2.2.    Overall High Cost Of Asthma And COPD Treatment

3.8.3.    Opportunities

3.8.3.1.    Increased Focus Towards Advanced Treatment Protocols

CHAPTER 4:    SMART INHALERS MARKET, BY PRODUCT

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Inhalers

4.2.1.    Key market trends and opportunities

4.2.2.    Market size and forecast

4.2.3.    Market analysis, by country

4.2.3.1.    Dry Powder Inhalers

4.2.3.2.    Metered Dose Inhalers

4.3.    Nebulizers

4.3.1.    Key market trends and opportunities

4.3.2.    Market size and forecast

4.3.3.    Market analysis, by country

CHAPTER 5:    SMART INHALERS MARKET, BY INDICATION

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Asthma

5.2.1.    Market size and forecast

5.2.2.    Market analysis, by country

5.3.    COPD

5.3.1.    Market size and Forecast

5.3.2.    Market analysis, by country

CHAPTER 6:    SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Hospital pharmacies

6.2.1.    Market size and forecast

6.2.2.    Market analysis, by country

6.3.    Retail Pharmacies

6.3.1.    Market size and forecast

6.3.2.    Market analysis, by country

6.4.    Online Pharmacies

6.4.1.    Market size and forecast

6.4.2.    Market analysis, by country

CHAPTER 7:    SMART INHALERS MARKET, BY REGION

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    North America

7.2.1.    Key market trends and opportunities

7.2.2.    North America market size and forecast, by product type

7.2.3.    North America market size and forecast, by indication

7.2.4.    North America market size and forecast, by distribution channel

7.2.6.    North America market size and forecast, by country

7.2.6.1.    U.S. market size and forecast, by product type

7.2.6.2.    U.S. market size and forecast, by indication

7.2.6.3.    U.S. market size and forecast, by distribution channel

7.2.6.5.    Canada market size and forecast, by product type

7.2.6.6.    Canada market size and forecast, by indication

7.2.6.7.    Canada market size and forecast, by distribution channel

7.2.6.8.    Mexico market size and forecast, by product type

7.2.6.9.    Mexico market size and forecast, by indication

7.2.6.10.    Mexico market size and forecast, by distribution channel

7.3.    Europe

7.3.1.    Key market trends and opportunities

7.3.2.    Europe market size and forecast, by product type

7.3.3.    Europe market size and forecast, by indication

7.3.4.    Europe market size and forecast, by distribution channel

7.3.5.    Europe market size and forecast, by country

7.3.5.1.    Germany market size and forecast, by product type

7.3.5.2.    Germany market size and forecast, by indication

7.3.5.3.    Germany market size and forecast, by distribution channel

7.3.5.4.    France market size and forecast, by product type

7.3.5.5.    France market size and forecast, by indication

7.3.5.6.    France market size and forecast, by distribution channel

7.3.5.8.    UK market size and forecast, by product type

7.3.5.9.    UK market size and forecast, by indication

7.3.5.10.    UK market size and forecast, by distribution channel

7.3.5.11.    Italy market size and forecast, by product type

7.3.5.12.    Italy market size and forecast, by indication

7.3.5.13.    Italy market size and forecast, by distribution channel

7.3.5.14.    Spain market size and forecast, by product type

7.3.5.15.    Spain market size and forecast, by indication

7.3.5.16.    Spain market size and forecast, by distribution channel

7.3.5.17.    Rest of Europe market size and forecast, by product type

7.3.5.18.    Rest of Europe market size and forecast, by indication

7.3.5.19.    Rest of Europe market size and forecast, by distribution channel

7.4.    Asia-Pacific

7.4.1.    Key market trends and opportunities

7.4.2.    Asia-Pacific market size and forecast, by product type

7.4.3.    Asia-Pacific market size and forecast, by indication

7.4.4.    Asia-Pacific market size and forecast, by distribution channel

7.4.5.    Asia-Pacific market size and forecast, by country

7.4.5.1.    Japan market size and forecast, by product type

7.4.5.2.    Japan market size and forecast, by indication

7.4.5.3.    Japan market size and forecast, by distribution channel

7.4.5.4.    China market size and forecast, by product type

7.4.5.5.    China market size and forecast, by indication

7.4.5.6.    China market size and forecast, by distribution channel

7.4.5.7.    India market size and forecast, by product type

7.4.5.8.    India market size and forecast, by indication

7.4.5.9.    India market size and forecast, by distribution channel

7.4.5.10.    Australia market size and forecast, by product type

7.4.5.11.    Australia market size and forecast, by indication

7.4.5.12.    Australia market size and forecast, by distribution channel

7.4.5.13.    Rest of Asia-Pacific market size and forecast, by product type

7.4.5.14.    Rest of Asia-Pacific market size and forecast, by indication

7.4.5.15.    Rest of Asia-Pacific market size and forecast, by distribution channel

7.5.    LAMEA

7.5.1.    Key market trends and opportunities

7.5.2.    LAMEA market size and forecast, by product type

7.5.3.    LAMEA market size and forecast, by indication

7.5.4.    LAMEA market size and forecast, by distribution channel

7.5.5.    LAMEA market size and forecast, by country

7.5.5.1.    Brazil market size and forecast, by product type

7.5.5.2.    Brazil market size and forecast, by indication

7.5.5.3.    Brazil market size and forecast, by distribution channel

7.5.5.4.    South Africa market size and forecast, by product type

7.5.5.5.    South Africa market size and forecast, by indication

7.5.5.6.    South Africa market size and forecast, by distribution channel

7.5.5.7.    Rest of LAMEA market size and forecast, by product type

7.5.5.8.    Rest of LAMEA market size and forecast, by indication

7.5.5.9.    Rest of LAMEA market size and forecast, by distribution channel

CHAPTER 8:    COMPANY PROFILES

8.1.    Adherium Limited

8.1.1.    Company overview

8.1.2.    Company snapshot

8.1.3.    Operating business segments

8.1.4.    Product portfolio

8.1.5.    Business performance

8.1.6.    Key strategic moves and developments

8.2.    AstraZeneca PLC

8.2.1.    Company overview

8.2.2.    Company snapshot

8.2.3.    Operating business segments

8.2.4.    Product portfolio

8.2.5.    Business performance

8.2.6.    Key strategic moves and developments

8.3.    Boehringer Ingelheim group

8.3.1.    Company overview

8.3.2.    Company snapshot

8.3.3.    Operating business segments

8.3.4.    Business performance

8.3.5.    Key strategic moves and developments

8.4.    Cohero Health, Inc.

8.4.1.    Company overview

8.4.2.    Company snapshot

8.4.3.    Product portfolio

8.4.4.    Business performance

8.4.5.    Key strategic moves and developments

8.5.    GlaxoSmithKline plc

8.5.1.    Company overview

8.5.2.    Company snapshot

8.5.3.    Operating business segments

8.5.4.    Product portfolio

8.5.5.    Business performance

8.5.6.    Key strategic moves and developments

8.6.    Novartis International AG

8.6.1.    Company overview

8.6.2.    Company snapshot

8.6.3.    Operating business segments

8.6.4.    Product portfolio

8.6.5.    Business performance

8.6.6.    Key strategic moves and developments

8.7.    OPKO Health, Inc.

8.7.1.    Company overview

8.7.2.    Company snapshot

8.7.3.    Operating business segments

8.7.4.    Product portfolio

8.7.5.    Business performance

8.8.    ResMed Inc. (Propeller Health)

8.8.1.    Company overview

8.8.2.    Company snapshot

8.8.3.    Operating business segments

8.8.4.    Product portfolio

8.8.5.    Business performance

8.8.6.    Key strategic moves and developments

8.9.    Teva Pharmaceutical Industries Limited

8.9.1.    Company overview

8.9.2.    Company snapshot

8.9.3.    Operating business segments

8.9.4.    Product portfolio

8.9.5.    Business performance

8.9.6.    Key strategic moves and developments

8.10.    Vectura Group plc

8.10.1.    Company overview

8.10.2.    Company snapshot

8.10.3.    Operating business segments

8.10.4.    Product portfolio

8.10.5.    Business performance

8.10.6.    Key strategic moves and developments

 

Chapter 9 Research Finding and Conclusion 

Chapter 10 Research Methodology 

Chapter 11  Research Data Source 

 

Tables

Figures